Article
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Neurology - 17 Jul 2012
Schöll Michael, Wall Anders, Thordardottir Steinunn, Ferreira Daniel, Bogdanovic Nenad, Långström Bengt, Almkvist Ove, Graff Caroline, Nordberg Agneta
Abstract excerpt
OBJECTIVE: To investigate the particular pathology of the Arctic APP (APParc) early-onset familial Alzheimer disease (eoFAD) mutation for the first time in vivo with PET in comparison with other eoFAD mutations and sporadic Alzheimer disease (sAD). METHODS: We examined 2 APParc mutation carriers together with 5 noncarrier siblings cross-sectionally with (11)C-labeled Pittsburgh compound B (PiB) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
